株式会社極東書店トップ ＞ 商品一覧 ＞ Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing.
商品詳細
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing.
・ISBN 978-0-367-73664-4 paper GB£ 54.99
￥17,420.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Yang, Harry, |
|---|---|
| シリーズ | Chapman & Hall/CRC Biostatistics Series |
| 出版社 | (Chapman & Hall/CRC, UK) |
| 出版年月 | 2020 |
| ページ数 | 386 pp. |
| 言語 | ENG |
| ニュース番号 | ＜M25-837＞ |
解説
The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.